Prosetta Biosciences Inc.

SAN FRANCISCO, CA · Founded 2013 · CIK 0001659956 · Biotech · Private

Small molecule therapeutics that modulate multi-protein complex assembly

prosetta.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$31M
1 Form D · Dec 2015
130 months since last filing
Contracts
—
No federal contracts on record
Patents
18
3 granted · 15 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$31,096,778
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2513Nouscom——
2514Somite AI——
2515Alligator Bioscience AB (publ)—$10M
2516Prosetta Biosciences Inc.—$31M
2517Metselex, Incorporated——
2518Radionetics Oncology—$54M
2519SIVEC BIOTECHNOLOGIES, INC.—$3.3M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Molly CoyeDirector
  • Michael FarmerDirector · Executive Officer
  • Thomas HigginsDirector
  • David KeysDirector
  • Vishwanath LingappaDirector · Executive Officer
  • Karl ManheimDirector
  • "Joseph(""Mike"")" McCuneDirector
  • Phil SatowDirector
  • CJ SylvesterDirector
  • Abel WeinribDirector

Patents

USPTO · 3 granted of 18

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.